NCT06827756View on ClinicalTrials.gov

Comparative Study of Secondary Prophylaxis for SBP

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

December 1, 2021

Study Completion Date

February 1, 2022

Conditions
Spontaneous Bacterial PeritonitisCirrhoses, LiverAscites
Interventions
DRUG

Norfloxacin 400 MG

Patients receiving Norfloxacin 400 Mg to prevent SBP

DRUG

Nitazoxanide 500 MG

Patients receiving Nitazoxaide 500 Mg to prevent SBP

DRUG

Colistin

Patients receiving Colistin 15ml three times/ day to prevent SBP

Trial Locations (1)

Unknown

Tanta University, Faculty of Medicine, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT06827756 - Comparative Study of Secondary Prophylaxis for SBP | Biotech Hunter | Biotech Hunter